| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics Incorporated (DGX) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. DGX is classified in the Health Care Providers & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 132.4K | $25.63M | -10,000 | |
| VP | 83.7K | $16.19M | - | |
| VP | 38.3K | $7.42M | - | |
| VP | 34.5K | $6.67M | - | |
| CFO | 33.4K | $6.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2017 | Rusckowski Stephen H64 | Chairman, President And CEO | Sale+OE | 2,525 | $108.03 | $272,768.18 | -1.5% | |
| Sep 5, 2017 | Stanzione Daniel | Director | Sale+OE | 3,803 | $108.01 | $410,762.03 | -9.9% | |
| Aug 4, 2017 | Leiden Jeffrey M47 | Director | Sell | 296 | $106.66 | $31,571.06 | -4.7% | |
| Jul 27, 2017 | Leiden Jeffrey M47 | Director | Sell | 1,304 | $108.73 | $141,782.62 | -17.2% | |
| Jun 19, 2017 | Doherty Catherine T.55 | SVP, Group Exec. Clin. Fran. | Sale+OE | 59,762 | $107.55 | $6,427,117.91 | -10.1% | |
| Jun 19, 2017 | Cohen Jon R | SVP &Group Exec. Diag. Sol. | Sale+OE | 106,900 | $107.55 | $11,497,134.22 | -12.4% | |
| Apr 24, 2017 | Britell Jenne K | Director | Sale+OE | 6,111 | $104.03 | $635,727.33 | -23.5% | |
| Apr 20, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 29,513 | $100.00 | $2,951,300.00 | -26.8% | |
| Mar 16, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sale+OE | 13,987 | $100.00 | $1,398,700.00 | -25.8% | |
| Mar 3, 2017 | Prevoznik Michael E52 | SVP &General Counsel | Sell | 4,478 | $98.29 | $440,142.62 | -10.0% |